Ignite Creation Date:
2025-12-26 @ 11:46 AM
Ignite Modification Date:
2026-02-24 @ 10:47 AM
Study NCT ID:
NCT02900716
Status:
COMPLETED
Last Update Posted:
2020-11-27
First Post:
2016-08-18
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Safety Study of BTK Inhibitor, DTRMWXHS-12, Used Singly or in Combination, in CLL and B-cell Lymphomas
Sponsor:
Zhejiang DTRM Biopharma
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
D15-11094
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None